CTRI/2022/02/039964招募中未知
A SINGLE-CENTER,PROSPECTIVE , RANDOMIZED, PARALLEL GROUP STUDY ONROLE OF SODIUM BICARBONATE THERAPY IN RETARDING CHRONIC KIDNEY DISEASE PROGRESSION - SOBIRC
INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH KOLKATA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •CKD STAGE 3 AND 4
- •SERUM BICARBONATE LESS THAN 22 MMOL/L
- •STABLE CLINICAL CONDITION AS ASSESSED BY TREATING PHYSICIA
排除标准
- •MORBID OBESITY
- •COGNITIVE IMPAIRMENT
- •POORLY CONTROLLED BLOOD PRESSURE
- •OVERT CONGESTIVE HEART FAILURE
- •AUTOIMMUNE DISEASE
- •LIMB AMPUTATION
- •POLYCYSTIC KIDNEY DISEASE
研究者
相似试验
暂停
不适用
This study is done to assess Effectiveness and Safety study of a three drug combination with a two drug combination for the treatment of type 2 diabetes mellitus in patients who have never received insulin.CTRI/2011/06/001841Abbott India Limited70
已完成
不适用
A NON-RANDOMIZED, MULTI-CENTER, PROSPECTIVE, SINGLE ARM CLINICAL STUDY OF THE X-SUIT NIR® COVERED BILIARY METALLIC STENT FOR PALLIATION OF MALIGNANT STRICTURES IN THE BILIARY TREE VIA ENDOSCOPIC APPROACHNL-OMON41690Medinol Ltd15
已完成
不适用
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, STUDY OF 12 WEEKS OF DURATION TO EVALUATE THE EFFICACY AND SAFETY OF MK-0524B (IN CODMINISTRATION OF DOSES OF MK-0524A AND SIMVASTATIN TABLETS) AGAINST ATORVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA MIXEDPER-070-08MERCK SHARP & DOHME PERU S.R.L.,9
进行中（未招募）
1 期
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY, COMPARING THE EFFICACY AND TOLERABILITY OF ZIPRASIDONE (ZELDOX®, GEODON®) VS OLANZAPINE (ZYPREXA®) IN THE TREATMENT AND MAINTENANCE OF RESPONSE IN PATIENTS WITH ACUTE MANIA - ZOOM STUDY: ZIPRASIDONE AND OLANZAPINE’S OUTCOMES IN MANIAMedDRA version: 8.1Level: LLTClassification code 10004939Bipolar I DisorderEUCTR2005-004391-21-FRPfizer Ltd - Sandwich Laboratories352
未知
不适用
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TWO DIFFERENT DOSES OF PALONOSETRON COMPARED TO ONDANSETRON IN THE PREVENTION OF CINV IN PEDIATRIC PATIENTS UNDERGOING SINGLE AND REPEATED CYCLES OF MEC OR HECPER-068-11Helsinn HealthCare S.A,19